DJIA 15,303.10 8.60 0.06%
NASDAQ 3,459.14 -0.28 -0.01%
S&P 500 1,649.60 -0.91 -0.06%

Eli Lilly & Co.

NYSE: LLY

+ Add to Portfolio

company name or ticker
Company Photos
(Click to zoom)
Working at Eli Lilly & Co.

Eli Lilly Ends Development of Lymphoma Drug Enzastaurin; Missed Study Endpoint

5/10/2013 by Smart Money

Benzinga's Top Pre-Market Losers

5/10/2013 by Benzinga

Eli Lilly's lymphoma drug fails in late-stage trial

5/10/2013 by Reuters

Lilly Announces Enzastaurin Phase III Study Did Not Meet Primary Endpoint in Diffuse Large B-Cell Ly

Lilly Announces Enzastaurin Phase III Study Did Not Meet Primary Endpoint in Diffuse Large B-Cell Lymphoma
5/10/2013 by Benzinga

Pharma’s Failure: Drug Spending Finally Declines

5/9/2013 by YCharts

Cellceutix Corporation: The Next Generation Of Cancer Treatment Has Arrived

5/9/2013 by Seeking Alpha

For Farmers, Rise in Suicide Rate Is Old News

What didn't make the papers last week is that for American farmers in economic distress, suicide has always been the leading killer.
5/8/2013 by Minyanville

For Farmers, Rise in Suicide Rate Is Old News

5/8/2013 by Nasdaq

Picking Up the Pieces of Another Alzheimer's Failure

What's next for Baxter's Gammagard and the future of Alzheimer's treatments?
5/7/2013 by DailyFinance

3 Bio Companies Facing The Patent Cliff

5/7/2013 by Seeking Alpha
See More Articles...